Haemonetics Corporation
$61.17
▲
1.05%
2026-04-21 07:14:01
www.haemonetics.com
NYQ: HAE
Explore Haemonetics Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.83 B
Current Price
$61.17
52W High / Low
$87.32 / $47.31
Stock P/E
16.14
Book Value
$19.46
Dividend Yield
—
ROCE
10.74%
ROE
19.3%
Face Value
—
EPS
$3.63
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
3,023
Beta
0.36
Debt / Equity
134.4
Current Ratio
1.75
Quick Ratio
0.99
Forward P/E
10.8
Price / Sales
2.04
Enterprise Value
$3.53 B
EV / EBITDA
9.66
EV / Revenue
2.67
Rating
Buy
Target Price
$86.9
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 2. | 908 Devices Inc. | $7.3 | 13.73 | $267.64 M | — | -16.46% | -25.77% | $9.34 / $4.2 | $3.96 |
| 3. | Co-Diagnostics, Inc. | $1.67 | — | $6.02 M | — | -147.54% | -1.26% | $46.5 / $1.35 | $9.85 |
| 4. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
| 5. | Artivion, Inc. | $38.8 | 193.48 | $1.89 B | — | 3.41% | 2.7% | $48.25 / $22.22 | $9.37 |
| 6. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 7. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 338.97 M | 327.31 M | 321.39 M | 330.6 M | 348.54 M |
| Operating Profit | 68.11 M | 67.08 M | 53.87 M | 50.7 M | 59.03 M |
| Net Profit | 44.74 M | 38.68 M | 34.03 M | 57.98 M | 37.49 M |
| EPS in Rs | 0.96 | 0.83 | 0.73 | 1.25 | 0.81 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.36 B | 1.31 B | 1.17 B | 993.2 M |
| Operating Profit | 201.19 M | 173.3 M | 155.65 M | 71.15 M |
| Net Profit | 167.68 M | 117.56 M | 115.4 M | 43.38 M |
| EPS in Rs | 3.61 | 2.53 | 2.48 | 0.93 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.45 B | 2.2 B | 1.93 B | 1.86 B |
| Total Liabilities | 1.63 B | 1.24 B | 1.12 B | 1.11 B |
| Equity | 820.84 M | 959.96 M | 818 M | 749.42 M |
| Current Assets | 934.98 M | 768.9 M | 769.72 M | 756.03 M |
| Current Liabilities | 578.11 M | 300.38 M | 251.82 M | 442.27 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 181.72 M | 181.75 M | 273.06 M | 172.26 M |
| Investing CF | -161.9 M | -322.39 M | -143.79 M | -86.34 M |
| Financing CF | 108.82 M | 38.16 M | -100.36 M | -15.75 M |
| Free CF | 142.45 M | 143.63 M | 81.73 M | 75.75 M |
| Capex | -39.28 M | -38.12 M | -191.33 M | -96.51 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 3.95% | 12.01% | 17.67% | — |
| Earnings Growth % | 42.64% | 1.87% | 166.05% | — |
| Profit Margin % | 12.32% | 8.98% | 9.87% | 4.37% |
| Operating Margin % | 14.78% | 13.24% | 13.32% | 7.16% |
| Gross Margin % | 55.04% | 52.83% | 52.63% | 50.9% |
| EBITDA Margin % | 24.79% | 20.02% | 21.34% | 17.97% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.